Acyl Coenzyme A Thioesterase 9: A Novel Target for Nonalcoholic Fatty Liver Disease by Shuttling Mitochondrial Short‐Chain Fatty Acids?
Xiaoxiao Jiang, Wen‐Xing Ding – 2 July 2020
Reply
Nobuhisa Akamatsu, Marc‐Antoine Allard, Kiyoshi Hasegawa – 1 July 2020
MiR‐125b Loss Activated HIF1α/pAKT Loop, Leading to Transarterial Chemoembolization Resistance in Hepatocellular Carcinoma
Xiyang Wei, Lei Zhao, Ruizhe Ren, Fubo Ji, Shuting Xue, Jianjuan Zhang, Zhaogang Liu, Zhao Ma, Xin W. Wang, Linda Wong, Niya Liu, Jiong Shi, Xing Guo, Stephanie Roessler, Xin Zheng, Junfang Ji – 1 July 2020
Clinical Features of Patients Infected With Coronavirus Disease 2019 With Elevated Liver Biochemistries: A Multicenter, Retrospective Study
Yu Fu, Rui Zhu, Tao Bai, Ping Han, Qin He, Mengjia Jing, Xiaofeng Xiong, Xi Zhao, Runze Quan, Chaoyue Chen, Ying Zhang, Meihui Tao, Jianhua Yi, Dean Tian, Wei Yan – 30 June 2020
Reproductive Health and Nonalcoholic Fatty Liver Disease in Women: Considerations Across the Reproductive Lifespan
Monika Sarkar, Ayako Suzuki – 30 June 2020
Issue Information
30 June 2020
AGA Clinical Practice Update on Interaction Between Oral Direct‐Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review
Amit G. Singal, Joseph K. Lim, Fasiha Kanwal – 30 June 2020
Update on Alpha‐1 Antitrypsin Deficiency in Liver Disease
Praveena Narayanan, Pramod K. Mistry – 30 June 2020
Highlights From the AASLD/EASL ALD Endpoints Conference 2019
Madeline Bertha, Haripriya Maddur – 30 June 2020
Risk Scores for Hepatocellular Carcinoma in Chronic Hepatitis B: A Promise for Precision Medicine
George V. Papatheodoridis, Thodoris Voulgaris, Margarita Papatheodoridi, W. Ray Kim – 30 June 2020